October 28th 2024
With the design of the new 360,000 square-foot building, the CDMO’s goal is to continue to modernize its Laupheim site.
October 8th 2024
With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain overall.
October 4th 2024
The goal is to provide greater access to HIV prevention drugs in low-income countries.
October 3rd 2024
Why it's critical for companies to set long-term, strategic goals in their journeys toward decarbonization.
October 2nd 2024
New facilities are expected to focus on manufacturing next-generation medicines and biologic medicines.
Fujifilm Invests $1.6 Billion toward Expansion of Cell Culture Manufacturing Services
Will benefit CDMO’s Denmark and Texas locations
Lonza to Construct Fill-finish Facility in Switzerland
With a cost of approximately $514 million, expected completion is 2026
Charles River Debuts UK Manufacturing Site
Cheshire facility will offer plasmid DNA production, CGT development
WuXi STA Opens HPAPI Facility in Changzhou, China
Marks the CDMO’s second plant in the country
BioNTech Breaks Ground on First mRNA Vaccine Manufacturing Facility in Africa
Containers to potentially be operational by next year, 2024 at the latest
MilliporeSigma Opens $65 Million HPAPI Facility
CDMO looks to combat cancer at lower doses
EMA Starts Rolling Review of Adapted COVID-19 Vaccines
Agency will be reviewing laboratory study and CMC data on the bivalent jab that targets two strains of the SARS-CoV-2 virus
Avid Bioservices Completes Phase One of Viral Vector Facility Construction
CDMO’s Costa Mesa location can start tackling oncology and rare disease treatment
Exothera Forms AAV Manufacturing Collaboration
Partnership aims to compare reproducibility and comparability between different suspension bioreactors
BioCina Unveils pDNA Manufacturing Suite
New service offering is GMP compliant, with single-use fermentation capacity of up to 300 L
Piramal Pharma Boosts API Services
Focus on operational excellence is playing a major role in this effort, company says
SK Pharmteco to Invest $35 Million toward Site Expansion
CDMO’s Ireland campus will increase in capacity by 50% as a result
Yourway to Construct Depot in Ireland
Will serve as a hub, as company aims for growth in the European region
REGENXBIO Opens Gene Therapy Manufacturing Center
GMP facility allows for an increase in AAV vector production
The Impact of War on Drug Supply Chain
A conversation with EY life sciences leaders Jim Welch and Jay Welsh
Dealing with Dangerous Goods
The packaging and shipping of dangerous goods (DG) adds further challenges to the distribution pressures brought about by the pandemic
Navigating Uneven Terrain in Labeling
The crucial link of labeling and packaging in the pharma supply chain has its glory, but is not without its set of obstacles amid current market and global challenges
Coriolis Pharma to Expand German HQ
Project is expected to grow CRDO’s capacity by over 150,000 square feet
Via Partnership, Evonik and US Government Invest $220 Million toward Lipid Production Plant
Facility, with expected completion of 2025, will specialize in mRNA-based therapies
Piramal Pharma Advances Oral Solid Dose Capabilities
As a result of new production area, India site’s total production capacity rises from 3 to 4.5 billion doses
Catalent Commits $175 Million to Upgrading Kentucky Facility
Investment will grow manufacturing capabilities at Winchester site
LOTTE to Purchase BMS Manufacturing Facility in New York
East Syracuse site will serve as a hub for company’s US biologics CDMO business
Cytiva Opening a New CGT Switzerland Facility
Among functions, 80,000 square-foot space will house a 'Center of Excellence'
PCI Pharma Services to Invest $100 Million in New Hampshire Facility
Location will feature aseptic fill-finish technology
Matica Bio Opens New Texas CGT Facility
Among efforts, part of center’s focus revolves providing tools for product commercialization
BeiGene Officially Breaks Ground on New Jersey Manufacturing and Clinical R&D Center
Facility will feature biologic manufacturing, along with late-stage research and clinical development of cancer medicines
Fujifilm Begins BioProcess Innovation Center Expansion Project
Expected to be ready by mid-2024
Catalent Obtains Erytech Pharma Manufacturing Facility
Deal for New Jersey cell therapy site totals $44.5 million
Scorpion Biological Services to Construct Kansas Biomanufacturing Facility
Commercial-scale center will cost $650 million, featuring 144,000 liters of biomanufacturing capacity
Asahi Kasei Medical Acquires Bionova Scientific
Deal adds biopharma services to its capabilities